0. Original

<p class=MsoNormal style='line-height:normal;text-autospace:none'><span
lang=EN-GB>Patients should be aware of circumstances where warning symptoms of
hypoglycaemia are diminished. The warning symptoms of hypoglycaemia may be
changed, be less pronounced or be absent in certain risk groups. These include
patients:</span></p>
<p class=MsoNormal style='margin-left:1.0cm;text-indent:-1.0cm;line-height:
normal;text-autospace:none'><span lang=EN-GB>-        in whom glycaemic control
is markedly improved,</span></p>
<p class=MsoNormal style='margin-left:1.0cm;text-indent:-1.0cm;line-height:
normal;text-autospace:none'><span lang=EN-GB>-        in whom hypoglycaemia
develops gradually,</span></p>
<p class=MsoNormal style='margin-left:1.0cm;text-indent:-1.0cm;line-height:
normal;text-autospace:none'><span lang=EN-GB>-        who are elderly,</span></p>
<p class=MsoNormal style='margin-left:1.0cm;text-indent:-1.0cm;line-height:
normal;text-autospace:none'><span lang=EN-GB>-        after transfer from
animal insulin to human insulin,</span></p>
<p class=MsoNormal style='margin-left:1.0cm;text-indent:-1.0cm;line-height:
normal;text-autospace:none'><span lang=EN-GB>-        in whom an autonomic
neuropathy is present,</span></p>
<p class=MsoNormal style='margin-left:1.0cm;text-indent:-1.0cm;line-height:
normal;text-autospace:none'><span lang=EN-GB>-        with a long history of
diabetes,</span></p>
<p class=MsoNormal style='margin-left:1.0cm;text-indent:-1.0cm;line-height:
normal;text-autospace:none'><span lang=EN-GB>-        suffering from a
psychiatric illness,</span></p>
<p class=MsoNormal style='margin-left:1.0cm;text-indent:-1.0cm;line-height:
normal;text-autospace:none'><span lang=EN-GB>-        receiving concurrent
treatment with certain other medicinal products (see section 4.5).</span></p>

1. Remove heading (remove first paragraph)

2. Remove lang (if equal to document languange) - otherwise output error

<p class=MsoNormal style='line-height:normal;text-autospace:none'><span>Patients should be aware of circumstances where warning symptoms of hypoglycaemia are diminished. The warning symptoms of hypoglycaemia may be changed, be less pronounced or be absent in certain risk groups. These include patients:</span></p>
<p class=MsoNormal style='margin-left:1.0cm;text-indent:-1.0cm;line-height:normal;text-autospace:none'><span>-        in whom glycaemic control is markedly improved,</span></p>
<p class=MsoNormal style='margin-left:1.0cm;text-indent:-1.0cm;line-height:normal;text-autospace:none'><span>-        in whom hypoglycaemia develops gradually,</span></p>
<p class=MsoNormal style='margin-left:1.0cm;text-indent:-1.0cm;line-height:normal;text-autospace:none'><span>-        who are elderly,</span></p>
<p class=MsoNormal style='margin-left:1.0cm;text-indent:-1.0cm;line-height:normal;text-autospace:none'><span>-        after transfer from animal insulin to human insulin,</span></p>
<p class=MsoNormal style='margin-left:1.0cm;text-indent:-1.0cm;line-height:normal;text-autospace:none'><span>-        in whom an autonomic neuropathy is present,</span></p>
<p class=MsoNormal style='margin-left:1.0cm;text-indent:-1.0cm;line-height:normal;text-autospace:none'><span>-        with a long history of diabetes,</span></p>
<p class=MsoNormal style='margin-left:1.0cm;text-indent:-1.0cm;line-height:normal;text-autospace:none'><span>-        suffering from a psychiatric illness,</span></p>
<p class=MsoNormal style='margin-left:1.0cm;text-indent:-1.0cm;line-height:normal;text-autospace:none'><span>-        receiving concurrent treatment with certain other medicinal products (see section 4.5).</span></p>

3. Determine resultant styling of paragraph (include class) and remove unnecessary styling

p.MsoNormal, li.MsoNormal, div.MsoNormal
	{margin:0cm;
	line-height:13.0pt;
	font-size:11.0pt;
	font-family:"Times New Roman",serif;}

<p><span>Patients should be aware of circumstances where warning symptoms of hypoglycaemia are diminished. The warning symptoms of hypoglycaemia may be changed, be less pronounced or be absent in certain risk groups. These include patients:</span></p>
<p><span>-        in whom glycaemic control is markedly improved,</span></p>
<p><span>-        in whom hypoglycaemia develops gradually,</span></p>
<p><span>-        who are elderly,</span></p>
<p><span>-        after transfer from animal insulin to human insulin,</span></p>
<p><span>-        in whom an autonomic neuropathy is present,</span></p>
<p><span>-        with a long history of diabetes,</span></p>
<p><span>-        suffering from a psychiatric illness,</span></p>
<p><span>-        receiving concurrent treatment with certain other medicinal products (see section 4.5).</span></p>

4. Simplify DOM

<p>Patients should be aware of circumstances where warning symptoms of hypoglycaemia are diminished. The warning symptoms of hypoglycaemia may be changed, be less pronounced or be absent in certain risk groups. These include patients:</p>
<p>-        in whom glycaemic control is markedly improved,</p>
<p>-        in whom hypoglycaemia develops gradually,</p>
<p>-        who are elderly,</p>
<p>-        after transfer from animal insulin to human insulin,</p>
<p>-        in whom an autonomic neuropathy is present,</p>
<p>-        with a long history of diabetes,</p>
<p>-        suffering from a psychiatric illness,</p>
<p>-        receiving concurrent treatment with certain other medicinal products (see section 4.5).</p>

5. Extract UL/OL

<p>Patients should be aware of circumstances where warning symptoms of hypoglycaemia are diminished. The warning symptoms of hypoglycaemia may be changed, be less pronounced or be absent in certain risk groups. These include patients:</p>
<ul>
<li>in whom glycaemic control is markedly improved,</li>
<li>in whom hypoglycaemia develops gradually,</li>
<li>who are elderly,</li>
<li>after transfer from animal insulin to human insulin,</li>
<li>in whom an autonomic neuropathy is present,</li>
<li>with a long history of diabetes,</li>
<li>suffering from a psychiatric illness,</li>
<li>receiving concurrent treatment with certain other medicinal products (see section 4.5).</li>
</ul>
